BANK OF AMERICA CORP /DE/ - 04 Nov 2019 Form 4 Insider Report for BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC. (DSM)

Role
10%+ Owner
Signature
BANK OF AMERICA CORP /DE By: Its: Authorized Signatory Andres Ortiz
Issuer symbol
DSM
Transactions as of
04 Nov 2019
Net transactions value
+$81,924
Form type
4
Filing time
13 Dec 2024, 16:34:02 UTC
Previous filing
13 Dec 2024
Next filing
13 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DSM Common Stock Sale $23,681 -2,808 -100% $8.43 0 04 Nov 2019 See Footnotes F1, F2, F3
transaction DSM Common Stock Purchase $23,910 +2,808 $8.52 0 05 Nov 2019 See Footnotes F1, F2, F3
transaction DSM Common Stock Purchase $8,103 +1,000 $8.10 1,000 28 Jan 2020 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $7,717 -950 -95% $8.12 50 03 Feb 2020 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $406 -50 -100% $8.13 0 03 Feb 2020 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $4,689 -625 -100% $7.50 0 04 Feb 2022 See Footnotes F1, F2, F3
transaction DSM Common Stock Purchase $744 +100 $7.44 0 04 Feb 2022 See Footnotes F1, F2, F3
transaction DSM Common Stock Purchase $744 +100 $7.44 0 04 Feb 2022 See Footnotes F1, F2, F3
transaction DSM Common Stock Purchase $2,230 +300 $7.44 0 04 Feb 2022 See Footnotes F1, F2, F3
transaction DSM Common Stock Purchase $744 +100 $7.44 0 04 Feb 2022 See Footnotes F1, F2, F3
transaction DSM Common Stock Purchase $186 +25 $7.44 0 04 Feb 2022 See Footnotes F1, F2, F3
transaction DSM Common Stock Purchase $101,677 +18,000 $5.65 18,000 23 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $476 -84 -0.47% $5.67 17,916 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $1,134 -200 -1.1% $5.67 17,716 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $566 -100 -0.56% $5.66 17,616 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $568 -100 -0.57% $5.68 17,516 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $567 -100 -0.57% $5.67 17,416 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $1,134 -200 -1.1% $5.67 17,216 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $1,871 -330 -1.9% $5.67 16,886 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $5,670 -1,000 -5.9% $5.67 15,886 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $566 -100 -0.63% $5.66 15,786 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $1,134 -200 -1.3% $5.67 15,586 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $567 -100 -0.64% $5.67 15,486 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $567 -100 -0.65% $5.67 15,386 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $2,268 -400 -2.6% $5.67 14,986 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $566 -100 -0.67% $5.66 14,886 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $566 -100 -0.67% $5.66 14,786 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $567 -100 -0.68% $5.67 14,686 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $566 -100 -0.68% $5.66 14,586 24 Mar 2023 See Footnotes F1, F2, F3
transaction DSM Common Stock Sale $567 -100 -0.69% $5.67 14,486 24 Mar 2023 See Footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This statement is jointly filed by Bank of America Corporation, Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), and BofA Securities, Inc ("BofA Securities") (collectively, the "Reporting Persons"). Bank of America Corporation holds an indirect interest in the securities listed in this Report by virtue of its 100% ownership of its subsidiaries Merrill Lynch and BofA Securities. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Securities Exchange Act of 1934 (the "Exchange Act"), or for any other purpose.
F2 Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the Exchange Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
F3 Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer.

Remarks:

Balance of trades included in attached schedule. (See Exhibit 99.1). Exhibit 99.2 - Joint Filing Agreement.